DACILON is a powerful cytotoxic agent that blocks DNA synthesis in tumor cells, slowing their growth and contributing to the destruction of cancerous cells. It is used for the treatment of various cancers, including ovarian tumors, sarcomas, and head and neck tumors. It is also effective in combination therapy for cancers that do not respond to other treatments.
The product is used for:
Ovarian cancer
Head and neck tumors
Sarcomas and other tumors
Treatment of recurrent cancer
DACILON is administered intravenously according to the scheme established by the doctor. It is typically prescribed in cycles of chemotherapy, with dosage depending on the type of tumor and the patient's condition. The drug should be administered in a hospital setting under the supervision of medical personnel.
Contraindications:
Hypersensitivity to dactinomycin or other components of the product
Pregnancy and breastfeeding
Liver and kidney dysfunction
Severe infectious diseases
Side Effects:
Nausea, vomiting
Fatigue, headache
Leukopenia, thrombocytopenia
Loss of appetite, dyspepsia
Allergic reactions (rash, itching)
